OBJECTIVE: The aim of this study was to determine the influence of menopause (hypoestrogenism) as a risk factor for oxidative stress. METHODS: We carried out a cross-sectional study with 187 perimenopausal women from Mexico City, including 94 premenopausal (mean ± SD age, 44.9 ± 4.0 y; estrogen, 95.8 ± 65.7 pg/mL; follicle-stimulating hormone, 13.6 ± 16.9 mIU/mL) and 93 postmenopausal (mean ± SD age, 52.5 ± 3.3 y; estrogen, 12.8 ± 6.8 pg/mL; follicle-stimulating hormone, 51.4 ± 26.9 mIU/mL) women. We measured lipoperoxides using a thiobarbituric acid-reacting substance assay, erythrocyte superoxide dismutase and glutathione peroxidase activities, and the total antioxidant status with the Randox kit. An alternative cutoff value for lipoperoxide level of 0.320 μmol/L or higher was defined on the basis of the 90th percentile of young healthy participants. All women answered the Menopause Rating Scale, the Athens Insomnia Scale, and a structured questionnaire about pro-oxidant factors, that is, smoking, consumption of caffeinated and alcoholic beverages, and physical activity. Finally, we measured weight and height and calculated body mass index. RESULTS: The lipoperoxide levels were significantly higher in the postmenopausal group than in the premenopausal group (0.357 ± 0.05 vs 0.331 ± 0.05 μmol/L, P = 0.001). Using logistic regression to control pro-oxidant variables, we found that menopause was the main risk factor for oxidative stress (odds ratio, 2.62; 95% CI, 1.35-5.11; P < 0.01). We also found a positive correlation between menopause rating score, insomnia score, and lipoperoxides, and this relationship was most evident in the postmenopausal group (menopause scale, r = 0.327 [P = 0.001]; insomnia scale, r = 0.209 [P < 0.05]). CONCLUSIONS: Our findings suggest that the depletion of estrogen in postmenopause could cause oxidative stress in addition to the known symptoms.
OBJECTIVE: The aim of this study was to determine the influence of menopause (hypoestrogenism) as a risk factor for oxidative stress. METHODS: We carried out a cross-sectional study with 187 perimenopausal women from Mexico City, including 94 premenopausal (mean ± SD age, 44.9 ± 4.0 y; estrogen, 95.8 ± 65.7 pg/mL; follicle-stimulating hormone, 13.6 ± 16.9 mIU/mL) and 93 postmenopausal (mean ± SD age, 52.5 ± 3.3 y; estrogen, 12.8 ± 6.8 pg/mL; follicle-stimulating hormone, 51.4 ± 26.9 mIU/mL) women. We measured lipoperoxides using a thiobarbituric acid-reacting substance assay, erythrocyte superoxide dismutase and glutathione peroxidase activities, and the total antioxidant status with the Randox kit. An alternative cutoff value for lipoperoxide level of 0.320 μmol/L or higher was defined on the basis of the 90th percentile of young healthy participants. All women answered the Menopause Rating Scale, the Athens Insomnia Scale, and a structured questionnaire about pro-oxidant factors, that is, smoking, consumption of caffeinated and alcoholic beverages, and physical activity. Finally, we measured weight and height and calculated body mass index. RESULTS: The lipoperoxide levels were significantly higher in the postmenopausal group than in the premenopausal group (0.357 ± 0.05 vs 0.331 ± 0.05 μmol/L, P = 0.001). Using logistic regression to control pro-oxidant variables, we found that menopause was the main risk factor for oxidative stress (odds ratio, 2.62; 95% CI, 1.35-5.11; P < 0.01). We also found a positive correlation between menopause rating score, insomnia score, and lipoperoxides, and this relationship was most evident in the postmenopausal group (menopause scale, r = 0.327 [P = 0.001]; insomnia scale, r = 0.209 [P < 0.05]). CONCLUSIONS: Our findings suggest that the depletion of estrogen in postmenopause could cause oxidative stress in addition to the known symptoms.
Authors: A A F Carioca; S M M L Verde; L A Luzia; P H C Rondó; M R D O Latorre; T H P Ellery; N R T Damasceno Journal: Eur J Clin Nutr Date: 2015-06-03 Impact factor: 4.016
Authors: Amir S Heravi; Erin D Michos; Di Zhao; Bharath Ambale-Venkatesh; Henrique Doria De Vasconcellos; Donald Lloyd-Jones; Pamela J Schreiner; Jared P Reis; Colin Wu; Cora E Lewis; James M Shikany; Stephen Sidney; Eliseo Guallar; Chiadi E Ndumele; Pamela Ouyang; Ron C Hoogeveen; Joao A C Lima; Dhananjay Vaidya; Wendy S Post Journal: J Womens Health (Larchmt) Date: 2022-06-08 Impact factor: 3.017
Authors: Kerrie L Moreau; Kerry L Hildreth; Jelena Klawitter; Patrick Blatchford; Wendy M Kohrt Journal: Geroscience Date: 2020-08-08 Impact factor: 7.713
Authors: Zhiping Hou; Mustapha Umar Imam; Maznah Ismail; Der Jiun Ooi; Aini Ideris; Rozi Mahmud Journal: Drug Des Devel Ther Date: 2015-08-14 Impact factor: 4.162